메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한산부인과학회 Obstetrics & Gynecology Science Obstetrics & Gynecology Science 제58권 제5호
발행연도
2015.1
수록면
340 - 345 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective To evaluate the performance of Momguard, non-invasive prenatal test (NIPT) for detecting trisomy (T) 21, T18, T13, andsex-chromosome abnormalities recently developed in Korea. Methods This preliminary study formed part of a large prospective cohort study conducted at Asan Medical Center, Seoul, Korea. Only pregnant women who underwent both NIPT and confirmatory karyotyping were included in this study. NIPTresults were compared with those of karyotype analyses. Results Among 93 eligible cases, NIPT results could not be obtained in one case due to a low fetal cell-free DNA fraction. Basedon NIPT, eight cases of fetal aneuploidies, including T21 (n=5), T18 (n=2), and T13 (n=1), were identified. For T21 andT18, the sensitivity and specificity of NIPT were both 100%, with a false-positive and false-negative rate of 0% and apositive-predictive value of 100%. One patient classified as having intermediate risk for T13 by NIPT was confirmedto have T13 by karyotyping, and there were no false-negative cases. No cases of sex-chromosome anomalies weredetected by NIPT or karyotyping during the study period. Conclusion Momguard is a reliable screening tool for detecting T21 and T18. For T13 and sex-chromosome anomalies, furtherprospective studies are necessary to confirm its utility.

목차

등록된 정보가 없습니다.

참고문헌 (18)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0